Published in Am J Med on August 01, 2008
Trends in comorbidity, disability, and polypharmacy in heart failure. Am J Med (2011) 1.80
Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction. JACC Heart Fail (2014) 1.12
Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial. Eur J Heart Fail (2010) 1.04
Associations of preexisting depression and anxiety with hospitalization in patients with cardiovascular disease. Mayo Clin Proc (2011) 0.99
Contemporary strategies in the diagnosis and management of heart failure. Mayo Clin Proc (2014) 0.98
Prognostic importance of comorbidities in heart failure with preserved left ventricular ejection fraction. Heart Vessels (2010) 0.96
Treating anemia in older adults with heart failure with a preserved ejection fraction with epoetin alfa: single-blind randomized clinical trial of safety and efficacy. Circ Heart Fail (2012) 0.86
Outcomes of patients with anemia and acute decompensated heart failure with preserved versus reduced ejection fraction (from the ARIC study community surveillance). Am J Cardiol (2014) 0.82
Characteristics and outcomes among heart failure patients with anemia and renal insufficiency with and without blood transfusions (public discharge data from California 2000-2006). Am J Cardiol (2011) 0.81
The role of erythropoietin stimulating agents in anemic patients with heart failure: solved and unresolved questions. Ther Clin Risk Manag (2014) 0.81
Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc (2016) 0.79
Patients with HFpEF and HFrEF have different clinical characteristics but similar prognosis: a retrospective cohort study. BMC Cardiovasc Disord (2016) 0.78
Blood volume measurements in patients with heart failure and a preserved ejection fraction: implications for diagnosing anemia. Congest Heart Fail (2011) 0.78
Who has advanced heart failure?: definition and epidemiology. Congest Heart Fail (2011) 0.77
Impact of epoetin alfa on left ventricular structure, function, and pressure volume relations as assessed by cardiac magnetic resonance: the heart failure preserved ejection fraction (HFPEF) anemia trial. Congest Heart Fail (2013) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Prediction of creatinine clearance from serum creatinine. Nephron (1976) 64.02
Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr (2005) 46.32
Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care (2003) 29.49
History of the Rochester Epidemiology Project. Mayo Clin Proc (1996) 21.72
An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol (1979) 18.84
Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med (2006) 17.13
Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation (1993) 9.24
Trends in heart failure incidence and survival in a community-based population. JAMA (2004) 8.90
Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood (2004) 5.86
Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation (2003) 4.43
Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation (2004) 3.56
Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation (2006) 3.31
Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol (2001) 3.14
Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol (2002) 2.97
Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation (2003) 2.49
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol (2001) 2.45
Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE). J Am Coll Cardiol (2003) 2.10
Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol (2002) 1.93
Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol (2007) 1.92
Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation (2006) 1.67
Superiority of visual versus computerized echocardiographic estimation of radionuclide left ventricular ejection fraction. Am Heart J (1989) 1.39
The prognostic importance of anemia in patients with heart failure. Am J Med (2003) 1.33
Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT. Circulation (2005) 1.14
Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial. Eur Heart J (2004) 1.13
Anemia in patients with heart failure and preserved systolic function. Am Heart J (2006) 1.10
Anaemia is an independent predictor of poor outcome in patients with chronic heart failure. Int J Cardiol (2003) 0.98
Relation of anemia to diastolic heart failure and the effect on outcome. Am J Cardiol (2004) 0.96
Anemia in chronic heart failure: pathogenetic mechanisms. J Card Fail (2004) 0.84
Anemia and heart failure a new pathway? J Am Coll Cardiol (2007) 0.80
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2009) 27.89
Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med (2006) 17.13
Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med (2011) 11.99
Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2010) 9.18
Trends in heart failure incidence and survival in a community-based population. JAMA (2004) 8.90
Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med (2012) 8.28
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13
Systolic and diastolic heart failure in the community. JAMA (2006) 5.99
Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum (2005) 5.31
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26
Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol (2009) 4.16
Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation (2007) 3.78
Myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, before and after smoke-free workplace laws. Arch Intern Med (2012) 3.77
Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol (2010) 3.63
Hospitalizations after heart failure diagnosis a community perspective. J Am Coll Cardiol (2009) 3.42
Why patients visit their doctors: assessing the most prevalent conditions in a defined American population. Mayo Clin Proc (2013) 3.40
Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester, Minn, 1970-1994. Arch Intern Med (2003) 3.13
Trends in incidence, severity, and outcome of hospitalized myocardial infarction. Circulation (2010) 3.07
Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail (2010) 3.01
Pulmonary pressures and death in heart failure: a community study. J Am Coll Cardiol (2012) 2.98
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol (2011) 2.89
Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994. Ann Intern Med (2002) 2.87
Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA (2011) 2.86
Unexplained pulmonary hypertension in elderly patients. Chest (2007) 2.85
Immunoreactivity and guanosine 3',5'-cyclic monophosphate activating actions of various molecular forms of human B-type natriuretic peptide. Hypertension (2007) 2.77
Redefinition of myocardial infarction: prospective evaluation in the community. Circulation (2006) 2.76
The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum (2005) 2.74
Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs. Circ Res (2008) 2.73
Age-associated increases in pulmonary artery systolic pressure in the general population. Circulation (2009) 2.70
Diastolic dysfunction and left atrial volume: a population-based study. J Am Coll Cardiol (2005) 2.69
Atrial fibrillation and death after myocardial infarction: a community study. Circulation (2011) 2.63
Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis. Circulation (2011) 2.63
Left atrial volume as an index of left atrial size: a population-based study. J Am Coll Cardiol (2003) 2.62
Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation (2005) 2.61
Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of "normal weight central obesity". J Am Coll Cardiol (2013) 2.61
Epidemiology of diastolic heart failure. Prog Cardiovasc Dis (2005) 2.59
Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction. Circ Heart Fail (2012) 2.53
Cardiac rehabilitation after myocardial infarction in the community. J Am Coll Cardiol (2004) 2.52
Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol (2011) 2.50
Death in heart failure: a community perspective. Circ Heart Fail (2008) 2.46
Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy. J Am Coll Cardiol (2012) 2.41
Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction. J Am Coll Cardiol (2009) 2.34
Coronary heart disease death and sudden cardiac death: a 20-year population-based study. Am J Epidemiol (2003) 2.34
Normal-Weight Central Obesity: Implications for Total and Cardiovascular Mortality. Ann Intern Med (2015) 2.31
Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study. Circ Heart Fail (2012) 2.26
Sudden death after myocardial infarction. JAMA (2008) 2.24
Secular trends in deaths from cardiovascular diseases: a 25-year community study. Circulation (2006) 2.24
Lifetime costs of medical care after heart failure diagnosis. Circ Cardiovasc Qual Outcomes (2010) 2.19
Electronic medical records for clinical research: application to the identification of heart failure. Am J Manag Care (2007) 2.18
Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data. JAMA (2009) 2.10
Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med (2006) 2.09
Coronary disease surveillance in Olmsted County objectives and methodology. J Clin Epidemiol (2002) 2.06
Impact of arterial load and loading sequence on left ventricular tissue velocities in humans. J Am Coll Cardiol (2007) 2.05
Incidence of heart failure after myocardial infarction: is it changing over time? Am J Epidemiol (2003) 2.03
Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community. Circulation (2011) 2.00
Scores for post-myocardial infarction risk stratification in the community. Circulation (2002) 1.98
A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc (2009) 1.98
Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol (2006) 1.98
The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum (2008) 1.94
Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. Circulation (2011) 1.92
Increased cardiovascular mortality after early bilateral oophorectomy. Menopause (2009) 1.89
Temporal trends in the incidence of coronary disease. Am J Med (2004) 1.86